FDA Adverse Event Injury Summary report: N

TEGADERM CHG DRESSING

MDR report key: 1894580 · Received November 5, 2010

Report

Report Number
2110898-2010-00124
Event Type
Injury
Date Received
November 5, 2010
Date of Event
October 3, 2010
Report Date
October 7, 2010
Manufacturer
3M HEALTH CARE
Product Code
FRO
PMA / PMN Number
K080620
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

CONCLUSIONS: NO EVAL WILL BE PERFORMED. DEVICE OR LOT CODE NOT PROVIDED TO MFR FOR EVAL. COMPLAINT TYPE WILL BE MONITORED. THE INSERT PROVIDES THE FOLLOWING INFO REGARDING OBSERVATION AND WHEN A DRESSING SHOULD BE CHANGED. SITE CARE: THE SITE SHOULD BE OBSERVED DAILY FOR SIGNS OF INFECTION OR OTHER COMPLICATIONS. IF INFECTION IS SUSPECTED, REMOVE THE DRESSING, INSPECT THE SITE DIRECTLY, AND DETERMINE APPROPRIATE MEDICAL INTERVENTION. INFECTION MAY BE SIGNALED BY FEVER, PAIN, REDNESS, SWELLING, OR UNUSUAL ODOR OR DISCHARGE. CHANGE THE DRESSING AS NECESSARY, IN ACCORDANCE WITH FACILITY PROTOCOL; DRESSING CHANGES SHOULD OCCUR AT LEAST EVERY 7 DAYS, PER CURRENT CDC RECOMMENDATIONS. DRESSING CHANGES MAY BE NEEDED MORE FREQUENTLY WITH HIGH EXUDATIVE SITES OR IF INTEGRITY OF THE DRESSING IS COMPROMISED.

Description of Event or Problem · 1

HEALTH CARE FACILITY REPORTED THAT A PT HAD DEVELOPED A SKIN IRRITATION UNDER THE ENTIRE DRESSING AT THE INSERTION SITE. THE CATHETER WAS REMOVED IN RESPONSE TO THE SKIN REACTION. A TOPICAL ANTIBIOTIC CREAM (MUPIROCIN) WAS USED TO TREAT THE CONDITION. THE OUTCOME OF THE SKIN CONDITION IS UNK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TEGADERM CHG DRESSING ANTIMICROBIAL IV SECUREMENT DRESSING FRO 3M HEALTH CARE NA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention CHLORAPREP| IV FLUIDS| CATHETER SECURED WITH RETENTION SUTURES| STAT-LOCK| ANTIBIOTICS